1 ANNEX I Biological products to be included in the Union antigen, vaccine and diagnostic reagent banks as referred to in Article 3, Regulation (EU) 2022/140

In forcesince 16 Nov 2021

Name of category A disease | Biological product | Type and/or strain of biological product | Number of doses | Validity period of biological product

1 | 2 | 3 | 4 | 5

Foot and mouth disease | antigen |

inactivated

various strains representing all seven serotypes: O, A, Asia 1, C, SAT1, SAT2, SAT3

at least 1000000 and up to 5000000 for each selected antigen, depending on the priority | at least 60 months

Classical swine fever | vaccine | live attenuated | at least 1000000 | at least 24 months

Infection with lumpy skin disease virus | vaccine | live attenuated or inactivated | at least 250000 | at least 20 months

Infection with peste des petits ruminants virus | vaccine | live attenuated or inactivated | at least 250000 | at least 20 months

Sheep pox and goat pox | vaccine | live attenuated or inactivated | at least 250000 | at least 20 months